Wang, Shuai <br/><br/>
Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer?  [electronic resource] 

 -  Oncotarget  Jul 2015 
 - 18206-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.4524  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chi-Square Distribution<br/>Disease Progression<br/>Disease-Free Survival<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Molecular Targeted Therapy<br/>Neoplasm Staging<br/>Odds Ratio<br/>Protein Kinase Inhibitors--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Risk Factors<br/>Signal Transduction--drug effects<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome